Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China
· Delayed Price · Currency is CNY 21.56
+0.65 (3.11%)
May 16, 2025, 3:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
| Cardiovascular | 300.41M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular Growth | 26.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-Tumor | 244.25M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-Tumor Growth | 73.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Women's Health | 188.85M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Women's Health Growth | -2.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory System | 163.29M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory System Growth | 7.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Trade | 105.28M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Trade Growth | 18.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Preparation | 89.85M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nervous System | 73.58M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nervous System Growth | -26.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-infection | 18.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-infection Growth | -60.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business | 8.59M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business Growth | 18.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 69.95M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 68.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
| Overseas | 1.09B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | 17.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 164.47M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 105.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Africa Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oceania | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|